Dow adds 834 points on Pfizer’s COVID-19 vaccine breakthrough as Nasdaq dips

The Dow and S&P 500 touched record highs before pulling back after Pfizer and BioNTech's COVID-19 vaccine proved to be 90% effective in trials. Investors bought stocks poised to benefit from a full reopening of the economy and they sold some of the hot stay-at-home stocks.

For more news, please go to FoxBusiness.com and watch Fox Business Network.

More NewslettersUnsubscribePrivacy PolicyContact Us

©2020 Fox News Network, LLC. 1211 Avenue of the Americas, New York, NY, 10036. All Rights Reserved. Privacy Policy

Fox Business never sends unsolicited email. You received this email because you requested a subscription to Fox Business Breaking News Alerts from FoxBusiness.com